Table 1 Association of BCCIP expression with triple negativity, p53, and BRCA1 status in breast cancer tissues

All cases

156 (33%)

317 (67%)

473

Triple negative

66 (49%)

70 (51%)

136

3.86 × 10^–7

Nontriple negative

80 (25%)

247 (75%)

327

p53 wild type

133 (35%)

252 (65%)

385

0.0018

p53 mutant

12 (16%)

62 (84%)

74

BRCA1 mutant (all triple negative)

1 (8%)

11 (92%)

12

0.0073 (compared with triple-negative tumors)